Top Medical Searches

FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy

February 9, 2017 — The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes… Read More..

Be Sociable, Share!
February 9th, 2017 Posted in NewDrugs
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us